Grant: Master's Award: Canada Graduate Scholarships
McGill University
$27,000.00
Establishing a Preclinical Mouse Model of Posterior Fossa A Ependymoma
EF 2024-25
Résumé
Ependymomas are one of the most common malignant pediatric brain tumours, with posterior fossa A (PFA) ependymoma being a particularly aggressive subtype which tends to affect young children, especially males (70%). The overall survival rate is only 50%, and current treatments, which include surgery followed by radiotherapy, can be damaging to the developing brain. The lack of both highly recurrent somatic mutations and a preclinical model system has made it challenging to understand the oncological mechanisms driving tumour growth. The establishment of a model system is desperately needed for the development of more successful treatments and targeted therapies. Here we propose to identify the mechanisms driving tumour growth in PFA ependymoma. We will investigate whether any significantly upregulated genes cooperate with EZHIP, a protein involved in chromatin modification and tumorigenesis, using lentiviral injections in mouse neural stem cells. We will also develop an immune-competent mouse model of PFA ependymoma using inducible CRISPR/Cas9 activation knock-in mice to target the upregulated genes together with coexpression of EZHIP. A preclinical model is essential to better understand tumorigenesis and develop improved treatments. The proposed research, when completed successfully, will help young patients with PFA ependymoma, as it opens the door to significant improvements in therapeutic strategies.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
529868
Name
Stuart Vanessa
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Establishing a Preclinical Mouse Model of Posterior Fossa A Ependymoma
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Ezhip; In-Vivo Crispr Screen; Mouse-Model; Oncological Mechanisms; Pediatric Brain Cancer; Posterior Fossa Ependymoma
Abstract
Ependymomas are one of the most common malignant pediatric brain tumours, with posterior fossa A (PFA) ependymoma being a particularly aggressive subtype which tends to affect young children, especially males (70%). The overall survival rate is only 50%, and current treatments, which include surgery followed by radiotherapy, can be damaging to the developing brain. The lack of both highly recurrent somatic mutations and a preclinical model system has made it challenging to understand the oncological mechanisms driving tumour growth. The establishment of a model system is desperately needed for the development of more successful treatments and targeted therapies. Here we propose to identify the mechanisms driving tumour growth in PFA ependymoma. We will investigate whether any significantly upregulated genes cooperate with EZHIP, a protein involved in chromatin modification and tumorigenesis, using lentiviral injections in mouse neural stem cells. We will also develop an immune-competent mouse model of PFA ependymoma using inducible CRISPR/Cas9 activation knock-in mice to target the upregulated genes together with coexpression of EZHIP. A preclinical model is essential to better understand tumorigenesis and develop improved treatments. The proposed research, when completed successfully, will help young patients with PFA ependymoma, as it opens the door to significant improvements in therapeutic strategies.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Stuart, Vanessa
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~